One health care sub-sector that experienced no major reform overhang is information technology. The move to electronic records for hospitals and physician practices was never in doubt.
The vote on repealing and replacing Obamacare has been pulled from the House floor.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
Merck KGaA shares tested one-year highs Friday after the Food & Drug Administration approved rare form of skin cancer treatment that could cost patients as much as $13,000 per month.